Safety of live attenuated influenza vaccine in atopic children with egg allergy

Live attenuated influenza vaccine (LAIV) is an intranasal vaccine recently incorporated into the United Kingdom immunization schedule. However, it contains egg protein and, in the absence of safety data, is contraindicated in patients with egg allergy. Furthermore, North American guidelines recommend against its use in asthmatic children.

Source: Journal of Allergy and Clinical Immunology - February 12, 2015 Category: Allergy & Immunology Authors: Paul J. Turner, Jo Southern, Nick J. Andrews, Elizabeth Miller, Michel Erlewyn-Lajeunesse, SNIFFLE Study Investigators Source Type: research